Both in Pharmaceuticals
Standard BioTools vs Lifecore Biomedical
Over the past year LAB returned −50.7% and LFCR returned −9.7%; their daily moves had a correlation of 0.09.
LAB −50.7% LFCR −9.7%Growth of $1, one year, split-adjusted
| Metric | LAB | LFCR |
|---|---|---|
| Price | $0.6108 | $6.42 |
| Market cap | $241.1M | $243.4M |
| Today | +0.15% | +0.47% |
| 1 month | −19.9% | −1.5% |
| 6 months | −37.6% | +24.4% |
| Year to date | −52.3% | −21.5% |
| 1 year | −49.1% | −10.7% |
| Revenue growth (YoY) | −7.6% | — |
| Gross margin | 52.4% | 35.3% |
| Net margin | −133.1% | −20.9% |
| P/E (TTM) | 2.8× | — |
| Price / sales | 2.8× | — |
| Net cash | $476.4M | -$136.9M |
| Dividend yield | — | — |
| Volatility (60d) | 45.5% | 96.9% |
| Short % of float | 1.1% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).